Skip to main content

Table 3 Cox regression analysis for disease-free and overall survival in tamoxifen-treated, hormone receptor positive patients

From: Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer

  Disease-free survival analysis Overall survival analysis
  Univariate Multivariate Univariate Multivariate
Variable P RR (95% CI) P RR (95% CI) P RR (95% CI) P RR (95% CI)
Grading 0.151 1.7 (0.82–3.16) - - 0.015 2.81 (1.22–6.5) 0.025 2.69 (1.13–6.4)
Lymph node status 0.284 1.89 (0.59–6.03) - - 0.055 3.81 (1.02–14.3) - -
Tumour size 0.013 2.25 (1.18–4.26) 0.023 2.24 (1.12–4.5) 0.002 3.43 (1.56–7.56) 0.005 3.83 (1.51–9.72)
FasL : Fas ratio 0.013 3.4 (1.29–8.96) 0.027 3.0 (1.14–7.9) 0.042 3.59 (1.05–12.3) 0.043 3.65 (1.04–12.8)
  1. The analysis was conducted in 86 women. CI, confidence interval; FasL, Fas ligand; RR, relative risk.